Skip to main content

Table 1 Baseline demographic and surgical characteristics

From: Collagen fleece-bound fibrin sealant is not associated with an increased risk of thromboembolic events or major bleeding after its use for haemostasis in surgery: a prospective multicentre surveillance study

  All patients (n = 3098) Patients with TEE (n = 46) Patients with major bleeding (n = 62) Patients with immunological event (n = 8)
Age (years), mean ± SD 60.7 ± 14.0 63.0 ± 10.0 58.6 ± 16.5 59.5 ± 11.8
Gender (female/male), % 43.7/56.3 28.3/71.7 32.3/67.7 37.5/62.5
BMI (kg/m2), mean ± SD 26.6 ± 4.9 27.2 ± 4.4 26.3 ± 6.1 26.0 ± 5.4
Type of surgery, n (%):     
Hepatic 1007 (32.5%) 22 (47.8%) 16 (25.8%) 3 (37.5%)
Gastrointestinal 500 (16.1%) 7 (15.2%) 13 (21.0%) 2 (25.0%)
Urological 422 (13.6%) 2 (4.3%) 6 (9.7%) 1 (12.5%)
Vascular 227 (7.3%) 5 (10.9%) 3 (4.8%) 0
Pulmonary 224 (7.2%) 4 (8.7%) 6 (9.7%) 1 (12.5%)
Cardiac 173 (5.6%) 0 5 (8.1%) 1 (12.5%)
Gynaecological 130 (4.2%) 0 1 (1.6%) 0
Neurosurgical 83 (2.7%) 2 (4.3%) 1 (1.6%) 0
Other 424 (13.7%) 4 (8.7%) 10 (16.1%) 0
Indication for surgery, n (%):     
Primary malignancy 1074 (34.7%) 20 (43.5%) 17 (27.4%) 3 (37.5%)
Secondary malignancy 619 (20.0%) 12 (26.1%) 7 (11.3%) 3 (37.5%)
Benign neoplastic disease 306 (9.9%) 2 (4.3%) 7 (11.3%) 0
Other 1098 (35.4%) 12 (26.1%) 31 (50.0%) 2 (25.0%)
Surgery, acute/elective, % 10.2/89.8 10.9/89.1 24.2/75.8 12.5/87.5
Duration of surgery (hours), mean ± SD 3.2 ± 1.8 4.4 ± 2.4 3.7 ± 2.4 4.4 ± 2.8
Patients receiving blood transfusion, n (%) 892 (28.8%) 14 (30.4%) 31 (50.0%) 2 (25.0%)
Number of transfusion units given, mean ± SD 5.2 ± 7.3 9.5 ± 12.1 10.0 ± 15.9 3.5 ± 2.1
Area of TachoSil used (cm2), mean ± SD 53.7 ± 40.7 60.1 ± 41.4 51.7 ± 36.3 55.1 ± 40.8